Frances de Jesus
View detailed information about Frances de Jesus, including compliance records, violations, and related data.
Person Profile
FDA investigator, Division of Pharmaceutical Quality Operations II.
Documents (5)
- WARNING LETTER · Nephron Pharmaceuticals Corporation · April 20, 2022
- WARNING LETTER · Nephron Sc Inc · April 20, 2022
- EIR · Pfizer Pharmaceuticals, LLC. · December 20, 2019
- EIR · USpharma, Ltd., Co. · June 23, 2022
- EIR · Huzhou Zhanwang Pharmaceutical Co., Ltd. · March 29, 2024
Related Office
Person Information
Name
Frances de Jesus
Title
Acting Program Division Director
Role
Regulatory Personnel
ID: b07b8929-85a5-4441-adff-74522fd8466a
Get More Insights
Access our comprehensive quality intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
1.5M+ regulatory data points
Real-time compliance monitoring
Interactive analytics dashboard
Looking for more people? Our platform provides access to thousands of FDA people with advanced search and filtering capabilities.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.